In High 2 or Basal groups, downregulation of GSTA1, GSTM1, GSTM2, and GSTT1 gene expression can be correlated with the impaired ability to eliminate carcinogenic compounds and increased cancer risk. This evidence concerns the gene GSTM2 and cancer.